PARA vs PMN · rev $5.0M vs P/E 4.8, $14.1M cap
PARA (PARA) versus ProMIS Neurosciences Inc. (PMN) — a side-by-side from cached financials, not a winner call.
PARA (PARA) common stock.
ProMIS Neurosciences Inc. (PMN) is a biotechnology company listed on US.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
PMN does not have a complete income-statement cache yet.
PARA currently screens at market cap $0. PMN currently screens at market cap $14.1M and trailing P/E 4.8.
Not investment advice. Open the PARA and PMN stock pages for the full models.
Not investment advice.